Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-004766-40Phase 2Terminated
Phase 2, randomised trial of nitroglycerin in stroke and hypertension (HTN) (2 arms), sponsored by University of Nottingham. Primary endpoint: Blood pressure at 2 hours after treatment. Started Feb 2008; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-004766-40.